REGENXBIO Is Maintained at Outperform by Leerink Partners

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

BUZZ-U.S. STOCKS ON THE MOVE-Abbvie, AMC, Getty

Thanks to SpaceX, Index Funds Won't Track Each Other as Closely. Here's One Pro's Advice. -- Barrons.com

Moderna Stock's 6-Day Rally Ends in a Dive. Why It's One of the S&P 500's Biggest Losers Today. -- Barrons.com

MoonLake’s SLK has ‘blockbuster potential,’ says Clear Street

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), MapLight Therapeutics, Inc. (MPLT)

US STOCKS-S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched

Arrowhead receives MAA in the EU for REDEMPLO

Arrowhead says EU grants marketing authorization for REDEMPLO in adult FCS patients

Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for Redemplo® (Plozasiran) to Reduce Triglycerides in Adults With Familial Chylomicronemia Syndrome (Fcs)

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN) and MoonLake Immunotherapeutics (MLTX)

Greenland Mines Shareholders Approve Reverse Stock Split Authorization

Greenland Mines Issues Shares for Strategic AnorTech Stake

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:17 PM

Apogee Therapeutics rises 46.8%

Amgen-backed real-world study finds thyroid eye disease progression risk nears 40% by year eight

Greenland Mines issues 12,400,000 shares to AnorTech in unregistered sale

Greenland Mines shareholders approve reverse stock split plan at special meeting